BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ierardi E, Goni E, Losurdo G, Di Mario F. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2014;19 Suppl 1:27-31. [PMID: 25167942 DOI: 10.1111/hel.12157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zaric S, Bojic B, Popovic B, Milasin J. Eradication of gastric Helicobacter pylori ameliorates halitosis and tongue coating. J Contemp Dent Pract. 2015;16:205-209. [PMID: 26057919 DOI: 10.5005/jp-journals-10024-1662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Han R, Lu H, Jiang MW, Tan KW, Peng Z, Hu JL, Fang DC, Lan CH, Wu XL. Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China. Gastroenterol Res Pract 2016;2016:8547686. [PMID: 27247569 DOI: 10.1155/2016/8547686] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
3 Abdel-Razik A, Mousa N, Elhelaly R, Elzehery R, Hasan AS, Abdelsalam M, Seif AS, Tawfik AM, El-Wakeel N, Eldars W. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Front Med (Lausanne) 2020;7:96. [PMID: 32266280 DOI: 10.3389/fmed.2020.00096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ierardi E, Losurdo G, Giorgio F, Di Leo A. Might helicobacter pylori play a role in allergic or cross-reaction related disorders? Expert Rev Gastroenterol Hepatol. 2020;14:643-646. [PMID: 32510247 DOI: 10.1080/17474124.2020.1780119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ierardi E, Losurdo G, Mileti A, Paolillo R, Giorgio F, Principi M, Di Leo A. The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science.Antibiotics (Basel). 2020;9. [PMID: 32486473 DOI: 10.3390/antibiotics9060293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Ferenc S, Gnus J, Kościelna M, Kinda M, Yarka A, Stewart L, Witkiewicz W. High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland. Helicobacter 2017;22. [PMID: 27879042 DOI: 10.1111/hel.12365] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
7 Losurdo G, Leandro G, Principi M, Giorgio F, Montenegro L, Sorrentino C, Ierardi E, Di Leo A. Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by ‘geographical weighting’. Int J Clin Pract. 2015;69:1112-1120. [PMID: 26138290 DOI: 10.1111/ijcp.12687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ierardi E, Giorgio F, Losurdo G, Sorrentino C, Principi M, Di Leo A. Detection of Helicobacter pylori DNA sequences in gastric biopsy samples to refine the diagnosis and therapy. J Med Microbiol. 2015;64:788-789. [PMID: 25934547 DOI: 10.1099/jmm.0.000075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Rostami-Nejad M, Javad Ehsani-Ardakani M, Assadzadeh H, Shahbazkhani B, Ierardi E, Losurdo G, Zojaji H, Alizadeh AM, Naderi N, Sadeghi A, Zali MR. Pathological and Clinical Correlation between Celiac Disease and Helicobacter Pylori Infection; a Review of Controversial Reports. Middle East J Dig Dis 2016;8:85-92. [PMID: 27252814 DOI: 10.15171/mejdd.2016.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Licinio R, Losurdo G, Carparelli S, Iannone A, Giorgio F, Barone M, Principi M, Ierardi E, Di Leo A. Helicobacter pylori , liver cirrhosis, and portal hypertension: an updated appraisal. Immunopharmacology and Immunotoxicology 2016;38:408-13. [DOI: 10.1080/08923973.2016.1247855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Mohammadian T, Ganji L. The Diagnostic Tests for Detection of Helicobacter pylori Infection. Monoclon Antib Immunodiagn Immunother 2019;38:1-7. [PMID: 30648911 DOI: 10.1089/mab.2018.0032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis. World J Gastroenterol 2018; 24(1): 139-149 [PMID: 29358890 DOI: 10.3748/wjg.v24.i1.139] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
13 Fernandes YC, Bonatto Gda R, Bonatto MW. Recurrence rate of Helicobacter pylori in patients with peptic ulcer five years or more after successful eradication. Arq Gastroenterol. 2016;53:152-155. [PMID: 27438419 DOI: 10.1590/s0004-28032016000300006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
14 Ierardi E, Losurdo G, Giorgio F, Iannone A, Principi M, Leo AD. Quinolone-based first, second and third-line therapies for Helicobacter pyloriWorld J Pharmacol 2015; 4(4): 274-280 [DOI: 10.5497/wjp.v4.i4.274] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Ierardi E, Losurdo G, Fortezza RFL, Principi M, Barone M, Leo AD. Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness. World J Gastroenterol 2019; 25(34): 5097-5104 [PMID: 31558859 DOI: 10.3748/wjg.v25.i34.5097] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
16 Reshetnyak VI, Reshetnyak TM. Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J Gastroenterol 2017; 23(27): 4867-4878 [PMID: 28785141 DOI: 10.3748/wjg.v23.i27.4867] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]